Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. 2017

Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas, Universidad de Valladolid, 47003 Valladolid, Spain.

Mutations in human LPIN2 produce a disease known as Majeed syndrome, the clinical manifestations of which are ameliorated by strategies that block IL-1β or its receptor. However the role of lipin-2 during IL-1β production remains elusive. We show here that lipin-2 controls excessive IL-1β formation in primary human and mouse macrophages by several mechanisms, including activation of the inflammasome NLRP3. Lipin-2 regulates MAPK activation, which mediates synthesis of pro-IL-1β during inflammasome priming. Lipin-2 also inhibits the activation and sensitization of the purinergic receptor P2X7 and K+ efflux, apoptosis-associated speck-like protein with a CARD domain oligomerization, and caspase-1 processing, key events during inflammasome activation. Reduced levels of lipin-2 in macrophages lead to a decrease in cellular cholesterol levels. In fact, restoration of cholesterol concentrations in cells lacking lipin-2 decreases ion currents through the P2X7 receptor, and downstream events that drive IL-1β production. Furthermore, lipin-2-deficient mice exhibit increased sensitivity to high lipopolysaccharide doses. Collectively, our results unveil lipin-2 as a critical player in the negative regulation of NLRP3 inflammasome.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010711 Phosphatidate Phosphatase A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4. Phosphatidate Phosphohydrolase,Phosphatidic Acid Phosphatase,Phosphatidic Acid Phosphohydrolase,Phosphatase, Phosphatidate,Phosphatase, Phosphatidic Acid,Phosphohydrolase, Phosphatidate,Phosphohydrolase, Phosphatidic Acid
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D000071199 NLR Family, Pyrin Domain-Containing 3 Protein An NLR protein that contains an N-terminal PYRIN DOMAIN and ATP-binding site and 9 C-terminal LEUCINE-rich repeats; it is expressed primarily by MACROPHAGES. It is a core component of the INFLAMMASOME and directs its assembly in response to pathogen infection and damage-associated stimuli. Mutations in the NLRP3 gene are associated with FAMILIAL COLD AUTOINFLAMMATORY SYNDROME. Cold Autoinflammatory Syndrome 1 Protein,NACHT, LRR and PYD Domains-Containing Protein 3,NLRP3 Protein,NACHT, LRR and PYD Domains Containing Protein 3,NLR Family, Pyrin Domain Containing 3 Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D048049 Extracellular Signal-Regulated MAP Kinases A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS. ERK MAP Kinase,ERK MAP Kinases,Extracellular Signal-Regulated Kinase,Extracellular Signal-Regulated Kinases,Extracellular Signal-Regulated MAP Kinase,MAP Kinases, Extracellular Signal-Regulated,Extracellular Signal Regulated Kinase,Extracellular Signal Regulated Kinases,Extracellular Signal Regulated MAP Kinase,Extracellular Signal Regulated MAP Kinases,Kinase, ERK MAP,Kinase, Extracellular Signal-Regulated,Kinases, Extracellular Signal-Regulated,MAP Kinase, ERK,MAP Kinases, Extracellular Signal Regulated,Signal-Regulated Kinase, Extracellular
D051197 Toll-Like Receptor 4 A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA. TLR4 Receptor,Toll-4 Receptor,Receptor, TLR4,Toll 4 Receptor,Toll Like Receptor 4

Related Publications

Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
January 2020, Cell & bioscience,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
November 2020, BMC biology,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
July 2017, Oncotarget,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
October 2020, Journal of immunology (Baltimore, Md. : 1950),
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
May 2021, Biochemical pharmacology,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
September 2019, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
June 2019, Nature communications,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
March 2024, The Journal of biological chemistry,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
August 2018, Inflammation,
Gema Lordén, and Itziar Sanjuán-García, and Nagore de Pablo, and Clara Meana, and Inés Alvarez-Miguel, and M Teresa Pérez-García, and Pablo Pelegrín, and Jesús Balsinde, and María A Balboa
March 2015, Nature communications,
Copied contents to your clipboard!